Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Joly

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Human Mutation|August 10, 2004
Genotype-phenotype correlation in von Hippel-Lindau families with renal lesionsCatherine Gallou, Dominique Chauveau, Stéphane Richard, et al.
Oncotarget|November 17, 2016
Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR groupStéphane Oudard, Reza Elaidi, Mara Brizard, et al.
Orphanet Journal of Rare Diseases|May 2, 2013
Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter studyThomas Stehlé, Dominique Joly, Philippe Vanhille, et al.
Orphanet Journal of Rare Diseases|December 19, 2014
Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre studyPatrick R Benusiglio, Sophie Giraud, Sophie Deveaux, et al.
Lancet (London, England)|June 4, 2013
Kidney failure: aims for the next 10 years and barriers to successGiuseppe Remuzzi, Ariela Benigni, Fredric O Finkelstein, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 2022
COVID-19 outbreak in vaccinated patients from a haemodialysis unit: antibody titres as a marker of protection from infectionIdris Boudhabhay, Alexandra Serris, Aude Servais, et al.
Journal of the American Society of Nephrology : JASN|January 25, 2011
Mutations in INF2 are a major cause of autosomal dominant focal segmental glomerulosclerosisOlivia Boyer, Geneviève Benoit, Olivier Gribouval, et al.
Wellcome Open Research|February 2, 2021
A simple ATAC-seq protocol for population epigeneticsRonaldo de Carvalho Augusto, Oliver Rey, Céline Cosseau, et al.
Kidney International|June 19, 2026
A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney diseaseDominique Joly, Moreno Ursino, Frank Bienaimé, et al.
Clinical Kidney Journal|February 10, 2022
Long-term impact of COVID-19 among maintenance haemodialysis patientsSylvain Chawki, Albert Buchard, Hamza Sakhi, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Human Mutation|August 10, 2004
Genotype-phenotype correlation in von Hippel-Lindau families with renal lesionsCatherine Gallou, Dominique Chauveau, Stéphane Richard, et al.
Oncotarget|November 17, 2016
Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR groupStéphane Oudard, Reza Elaidi, Mara Brizard, et al.
Orphanet Journal of Rare Diseases|May 2, 2013
Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter studyThomas Stehlé, Dominique Joly, Philippe Vanhille, et al.
Orphanet Journal of Rare Diseases|December 19, 2014
Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre studyPatrick R Benusiglio, Sophie Giraud, Sophie Deveaux, et al.
Lancet (London, England)|June 4, 2013
Kidney failure: aims for the next 10 years and barriers to successGiuseppe Remuzzi, Ariela Benigni, Fredric O Finkelstein, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 2022
COVID-19 outbreak in vaccinated patients from a haemodialysis unit: antibody titres as a marker of protection from infectionIdris Boudhabhay, Alexandra Serris, Aude Servais, et al.
Journal of the American Society of Nephrology : JASN|January 25, 2011
Mutations in INF2 are a major cause of autosomal dominant focal segmental glomerulosclerosisOlivia Boyer, Geneviève Benoit, Olivier Gribouval, et al.
Wellcome Open Research|February 2, 2021
A simple ATAC-seq protocol for population epigeneticsRonaldo de Carvalho Augusto, Oliver Rey, Céline Cosseau, et al.
Kidney International|June 19, 2026
A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney diseaseDominique Joly, Moreno Ursino, Frank Bienaimé, et al.
Clinical Kidney Journal|February 10, 2022
Long-term impact of COVID-19 among maintenance haemodialysis patientsSylvain Chawki, Albert Buchard, Hamza Sakhi, et al.
Pageof 10